Aptevo Therapeutics Inc. Gains 35.08%
Wed, May 01, 2024 at 07:21 PM
Aptevo Therapeutics Inc. (APVO:NASDAQ) soared at $0.96, a gain of 35.1%. On Wed, May 01, 2024, APVO:NASDAQ touched a New 2-Week High of $0.96. The stock got featured on our News Catalysts scanner on Mon, Apr 15, 2024 at 04:53 PM in the 'PUBLIC OFFERING' category. From Wed, Apr 17, 2024, the stock recorded 50.00% Up Days and 36.36% Green Days
The stock spiked on Thu, Mar 07, 2024 at $10.8 with a volume of 3M+.
About Aptevo Therapeutics Inc. (APVO:NASDAQ)
Aptevo Therapeutics Inc is a biosciences company. The Company is engaged in the discovery, development, commercialization and sale of novel oncology and hematology therapeutics.
Top 10 Gainers:
- CytomX Therapeutics, Inc. (CTMX:NASDAQ), 214.72%
- SYLA Technologies Co. Ltd. (SYT:NASDAQ), 122.45%
- The Real Good Food Company Inc. (RGF:NASDAQ), 73.14%
- BioAtla Inc. (BCAB:NASDAQ), 49.45%
- Latch Inc. (LTCH:NASDAQ), 37.97%
- Aptevo Therapeutics Inc. (APVO:NASDAQ), 35.08%
- Psyence Biomedical Ltd. (PBM:NASDAQ), 33.41%
- a.k.a. Brands Holding Corp. (AKA:NYSE), 31.63%
- Mediaco Holding Inc. (MDIA:NASDAQ), 30.68%
- Surmodics, Inc. (SRDX:NASDAQ), 29.74%